Rationale and Design of the AutoHealth Study: Prospective clinical validation of continuous multimodal in-vehicle health monitoring in real-world mobility
Clicks: 2
ID: 321718
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
2 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #3 of 55 articles by views in European Heart Journal - Digital Health
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Continuous physiological monitoring outside clinical environments remains limited by usability, reproducibility and user adherence. Vehicles offer a semi-controlled setting enabling unobtrusive multimodal sensing during everyday mobility. The Automotive Health Proof of Concept Trial (AutoHealth) investigates real-world feasibility and accuracy of continuous in-vehicle cardiovascular monitoring using integrated optical, electrical and acoustic sensors benchmarked against medical-grade reference standards. Methods/Design AutoHealth is a prospective, observational cohort study at Charité – Universitätsmedizin Berlin enrolling adults across five predefined cohorts: healthy individuals, patients with an elevated cardiometabolic risk, HFpEF, HFrEF and persistent atrial fibrillation. Participants undergo comprehensive baseline phenotyping followed by a structured in-vehicle session comprising static and dynamic driving segments and predefined physical and cognitive stress tasks. Synchronized biosignals including rPPG, steering-wheel ECG, phonocardiography and voice-derived features are compared with clinical reference measurements. The primary endpoint is the median absolute percentage error (MAPE) of in-vehicle vital sign estimates versus reference measurements, with successful performance defined a priori as MAPE ≤10%. Secondary endpoints include the proportion of measurements meeting predefined clinical accuracy thresholds, arrhythmia detection performance, characterization of autonomic stress response and correlations with functional mobility metrics. The study adheres to STROBE and SPIRIT-AI guidelines and is registered in the German Clinical Trials Register. Discussion AutoHealth is designed to provide a prospective clinical validation of continuous multimodal cardiovascular monitoring inside a modified production vehicle under real-world driving conditions and reproducible closed-course testing. Study findings will characterize feasibility, performance and translational potential of Automotive Health as a scalable prevention and remote physiological monitoring paradigm.
| Reference Key |
openalex_W7169866196
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Dominik Naumann, Tatjana Amler, Doreen Schöppenthau, Sergej Holzmann, Jörg Preißinger, Matthias Franz, Nils Hinrichs, Felix Schoenrath, Alexander Meyer |
| Journal | European Heart Journal - Digital Health |
| Year | 2026 |
| DOI |
10.1093/ehjdh/ztag114
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.